Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study

Journal of Psychopharmacology

Volumn 23, Issue 8, 2009, Pages 883-890

  Caputo, F ^a,b   Francini, S ^a   Stoppo, M ^a   Lorenzini, F ^a   Vignoli, T ^a   Del Re, A ^c   Comaschi, C ^c   Leggio, L ^d   Addolorato, G ^d   Zoli, G ^b   Bernardi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SS Annunziata Hospital   (Italy)

^c Azienda USL di Bologna   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Craving for and abuse of gamma hydroxybutyric acid; Different population of alcoholics; Treatment of alcohol dependence

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALCOHOL; COCAINE; DIAMORPHINE; METHADONE;

ADULT; ALCOHOLISM; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; COCAINE DEPENDENCE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEROIN DEPENDENCE; HUMAN; MAINTENANCE THERAPY; MALE; MORBIDITY; OPEN STUDY; PHYSICIAN; POPULATION; PRIORITY JOURNAL; REMISSION; VERTIGO; WITHDRAWAL SYNDROME;

ADULT; ALCOHOLICS; ALCOHOLISM; FEMALE; HUMANS; HYDROXYBUTYRATES; MALE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS;

EID: 67649632493     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108094620     Document Type: Article

References (46)

1. Addolorato, G., Balducci, G., Capristo, E., Attilia, ML, Taggi, F., Gasbarrini, G., et al. (1999) Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol Clin Exp Res 23: 1596-1604.
2. Addolorato, G., Caputo, F., Capristo, E., Domenicali, M., Bernardi, M., Janiri, L., et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37: 504-508.
3. Addolorato, G., Castelli, E., Stefanini, GF, Casella, G., Caputo, F., Marsigli, L., et al. (1996) An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol Alcohol 31: 341-345.
4. Addolorato, G., Cibin, M., Caputo, F., Capristo, E., Gessa, GL, Stefanini, GF, et al. (1998) Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients. Drug Alcohol Depend 53: 7-10.
5. Agabio, R., Colombo, G., Loche, A., Lobina, C., Pani, ML, Reali, R., et al. (1998) Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism. Alcohol Alcohol 33: 465-474.
6. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth ed. [Text Revision]. Washington, DC: American Psychiatric Association.
7. Anderson, SM, Pierce, RC (2005) Cocaine-induced alterations in dopamine receptor signalling: implications for reinforcement and reinstatement. Pharmacol Ther 106: 389-403.
8. Assadi, SM, Radgoodarzi, R., Ahmadi-Abhari, SA (2003) Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial. BMC Psychiatry 3: 16.
9. Caputo, F., Addolorato, G., Lorenzini, F., Domenicali, M., Greco, G., Del Re, A., et al. (2003) Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study. Drug Alcohol Depend 70: 85-91.
10. Caputo, F., Addolorato, G., Trevisani, F., Bernardi, M. (2005) Gamma-hydroxybutyrate as a treatment for alcoholism. Lancet 366: 981-982.
11. Centers for Disease Control and Prevention (CDC) (2001) Cigarette smoking among adults-United States, 1999. MMWR Morb Mortal Wkly Rep 50: 869-873.
12. Colombo, G., Agabio, R., Lobina, C., Reali, R., Fadda, F., Gessa, GL (1995) Cross-tolerance to ethanol and gamma-hydroxybutyric acid. Eur J Pharmacol 273: 235-238.
13. Conway, KP, Compton, W., Stinson, FS, Grant, BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67: 247-257.
14. Dagher, A., Bleicher, C., Aston, JA, Gunn, RN, Clarke, PB, Cumming, P. (2001) Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse 42: 48-53.
15. Gallimberti, L., Canton, G., Gentile, N., Ferri, M., Cibin, M., Ferrara, SD, et al. (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2: 787-789.
16. Gallimberti, L., Ferri, M., Ferrara, SD, Fadda, F., Gessa, GL (1992) gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res 16: 673-676.
17. Gallimberti, L., Spella, MR, Soncini, CA, Gessa, GL (2000) Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20: 257-262.
18. Gessa, GL, Agabio, R., Carai, M., Lobina, C., Pani, M., Reali, R., et al. (2000) Mechanism of the anti-alcohol effect of gamma-hydroxybutyric acid (GHB). Alcohol 20: 271-276.
19. Grant, BF, Stinson, FS, Dawson, DA, Chou, SP, Dufour, MC, Compton, W., et al. (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61: 807-816.
20. Janiri, L., Martinotti, G., Dario, T., Reina, D., Paparello, F., Pozzi, G., et al. (2005) Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology 52: 37-44.
21. Jayaram, P., Steketee, JD (2004) Effects of repeated cocaine on medial prefrontal cortical GABAB receptor modulation of neurotransmission in the mesocorticolimbic dopamine system. J Neurochem 90: 839-847.
22. Kalivas, PW, Volkow, ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413.
23. Kenna, GA, Nielsen, DM, Mello, P., Schiels, A., Swift, R. (2007) Pharmacotherapy of dual substance abuse and dependence. CNS Drugs 21: 213-237.
24. Kessler, RC (2004) The epidemiology of dual diagnosis. Biol Psychiatry 56: 730-737.
25. Kushner, SA, Unterwald, EM (2001) Chronic cocaine administration decreases the functional coupling of GABAB receptors in the rat ventral tegmental area as measured by baclofen-stimulated SGTP3S binding. Life Sci 69: 1093-1102.
26. Lehert, P. (1993) Review and discussion of statistical analysis of controlled clinical trials in alcoholism. Alcohol Alcohol 28: 157-163.
27. Martin, TJ, Kahn, WR, Xiao, R., Childers, SR (2007) Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain. Synapse 61: 176-184.
28. Miller, NS, Summers, GL, Gold, MS (1993) Cocaine dependence: alcohol and other drug dependence and withdrawal characteristic. J Addict Disord 12: 25-35.
29. Nava, F., Premi, S., Manzato, E., Campagnola, W., Lucchini, A., Gessa, GL (2007) Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam. Am J Drug Alcohol Abuse 33: 379-392.
30. Nestler, EJ, Terwilliger, RZ, Walker, JR, Sevarino, KA, Duman, RS (1990) Chronic cocaine treatment decreases levels of the G protein subunits Gi± and Go± in discrete regions of rat brain. J Neurochem 55: 1079-1082.
31. Nimmerrichter, AA, Walter, H., Gutierrez-Lobos, KE, Lesch, OM (2002) Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol 37: 67-73.
32. OMalley, SS, Jaffe, AJ, Chang, G., Schottenfeld, RS, Meyer, RE, Rounsaville, B. (1992) Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49: 881-887.
33. Pardi, D., Black, J. (2006) gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs 20: 993-1018.
34. Queyen, QT, Mausbach, B. (2007) Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res 31: 513-536.
35. Ricaurte, GA, McCann, UD (2005) Recognition and management of complications of new recreational drug use. Lancet 365: 2137-2145.
36. Rosen, MI, Pearsall, HR, Woods, SW, Kosten, TR (1997) Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients. J Subst Abuse Treat 14: 149-154.
37. Schmidt, K., Nolte-Zenker, B., Patzer, J., Bauer, M., Schimdt, GL, Heinz, A. (2001) Psychopharmacol 34: 66-72.
38. Secretary and Human Services (1997) Ninth Special Report to the U.S. Congress on Alcohol and Health (NIH publication 97-4017). Washington, DC: U.S. Government Printing Office.
39. Shi, J., Zhao, LY, Copersino, ML, Fang, YX, Chen, Y., Tian, J., et al. (2008) PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 28: 160-166.
40. Shoji, S., Simms, D., McDaniel, WC, Gallagher, JP (1997) Chronic cocaine enhances gamma-aminobutyric acid and glutamate release by altering pre-synaptic and not post-synaptic 3-aminobutyric acid B receptors within the rat dorsolateral septal nucleus. J Pharmacol Exp Ther 280: 129-137.
41. Shoptaw, S., Yang, X., Rotheram-Fuller, EJ, Hsieh, YC, Kintaudi, PC, Charuvastra, VC, et al. (2003) Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 64: 1440-1448.
42. Snead, OC, Gibson, KM (2005) Gamma-hydroxybutyric acid. N Engl J Med 352: 2721-2732.
43. Staines, GL, Magura, S., Foote, J., Deluca, A., Kosanke, N. (2001) Poly-substance use among alcoholics. J Addict Dis 20: 53-69.
44. Volkow, ND, Fowler, JS, Wang, GJ, Swanson, JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9: 557-569.
45. Xi, ZX, Ramamoorthy, S., Shen, H., Lake, R., Samuvel, DJ, Kalivas, PW (2003) GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci 23: 3498-3505.
46. Yasuno, F., Ota, M., Ando, K., Ando, T., Maeda, J., Ichimiya, T., et al. (2007) Role of ventral striatum dopamine D1 in cigarette craving. Biol Psychiatry 61: 1252-1259.